79% of Canadians Support Psilocybin To Treat Existential Dread for End of Life Patients
A team of Canadian researchers recently published the results of their newest study in the medical journal Palliative Medicine. The study examined the social acceptability of using psilocybin as an end of life treatment, specifically to treat “existential dread.” According to study team leader Michel Dorval, who is a researcher at CHU de Québec-Université Laval